| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 7 |
| 1 | FUROSEMIDE | 6 |
| 2 | BICALUTAMIDE | 4 |
| 3 | CALCIUM CARBONATE | 4 |
| 4 | PANTOPRAZOLE | 4 |
| 5 | PREDNISONE | 4 |
| 6 | ACALABRUTINIB | 3 |
| 7 | ACETAMINOPHEN | 3 |
| 8 | ACETAMINOPHEN 500MG | 3 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PYRIDOXINE HYDROCHLORIDE | 3 | 0.0011 |
| 1 | TRIPTORELIN | 2 | 0.0006 |
| 2 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 3 | HUMAN INSULIN | 3 | 0.0004 |
| 4 | IOPAMIDOL | 1 | 0.0003 |
| 5 | ALFUZOSIN HCL | 1 | 0.0003 |
| 6 | BICALUTAMIDE | 4 | 0.0003 |
| 7 | FRUQUINTINIB | 1 | 0.0003 |
| 8 | ACALABRUTINIB | 3 | 0.0002 |
| 9 | POSACONAZOLE | 3 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 8 |
| 1 | Loop Diuretic [EPC] | 6 |
| 2 | Azole Antifungal [EPC] | 5 |
| 3 | Corticosteroid [EPC] | 5 |
| 4 | Androgen Receptor Inhibitor [EPC] | 4 |
| 5 | Central Nervous System Stimulant [EPC] | 3 |
| 6 | GLP-1 Receptor Agonist [EPC] | 3 |
| 7 | Insulin [EPC] | 3 |
| 8 | Janus Kinase Inhibitor [EPC] | 3 |
| 9 | Kinase Inhibitor [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 1 | Vitamin D3 Analog [EPC] | 2 | 0.0001 |
| 2 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 3 | Androgen [EPC] | 2 | 0.0001 |
| 4 | Insulin [EPC] | 3 | 0.0001 |
| 5 | Androgen Receptor Inhibitor [EPC] | 4 | 0.0001 |
| 6 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 7 | Central Nervous System Stimulant [EPC] | 3 | 0.0000 |
| 8 | Azole Antifungal [EPC] | 5 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 8 | 0.0000 |